Fusion genes in pancreatic tumors

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Gene fusions and rearrangements are significant in tumor biology, particularly in KRAS wild-type pancreatic cancers.
• These genomic alterations are often rare but hold substantial clinical implications.

Purpose of the Study:

• To review the literature on fusion genes in pancreatic tumors.
• To explore their clinical potential as biomarkers and therapeutic targets.

Main Methods:

• Literature review of existing studies on gene fusions in pancreatic cancer.
• Analysis of the diagnostic and therapeutic relevance of identified fusion genes.

Main Results:

• Fusion genes are key in KRAS wild-type pancreatic tumors, involving actionable targets like BRAF, FGFR2, RET, NTRK, NRG1, and ALK.
• Specific fusions, such as PRKACA/B, are diagnostic hallmarks for intraductal oncocytic papillary neoplasms (IOPNs).

Conclusions:

• The identification of fusion genes is critical for precision oncology and diagnosis in pancreatic cancer.
• Quality-assured molecular diagnostics are essential for leveraging the therapeutic and diagnostic value of these rare genomic events.